Medispec
14
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
36%
5 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
ESWT as a Treatment for Chronic NHO in TBI Patients
Role: collaborator
Efficacy of Extracorporeal Shockwave Myocardial Revascularization Therapy in Patients With Stable Angina Pectoris
Role: collaborator
Safety and Efficacy Study of Extracorporeal Shockwave Therapy in the Treatment of Patients With Resistant Hypertension
Role: lead
Extracorporeal Shockwave Myocardial Revascularization (ESMR) Therapy For The Treatment of Chronic Heart Failure
Role: lead
Extracorporeal Shockwave Therapy for the Treatment of Advanced Angina Pectoris
Role: lead
Extracorporeal Shockwave Therapy for the Treatment of Refractory Angina Pectoris
Role: lead
Extracorporeal Shock Wave Therapy for the Treatment of Ischemic Heart Disease
Role: lead
The Effect of Low Intensity Shock Wave Therapy for ED in PDE5i Non Responders
Role: collaborator
Extracorporeal Shockwave Therapy for the Treatment of Chronic Angina Pectoris
Role: lead
Extracorporeal Shockwave Therapy for the Treatment of Refractory Chronic Angina Pectoris
Role: lead
The Effect of Low Intensity Shockwave Therapy for ED in Post Radical Prostatectomy Patients Who Didn't Respond to PDE5i
Role: collaborator
Double Blind Placebo Controlled Study on the Effect of Extracorporal Shock Wave Therapy on Erectile Dysfunction in PDE5i Responders
Role: collaborator
Extracorporeal Shock Wave Therapy for the Treatment of Erectile Dysfunction
Role: lead
Double Blind Placebo Controlled Study on the Effect of Extracorporal Shock Wave Therapy on Erectile Dysfunction
Role: collaborator
All 14 trials loaded